$CSBR
CHAMPIONS ONCOLOGY, INC. Stock $csbr

$csbr Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-Q Financial Statement

#000162828020003637 Filed on March 16, 2020

Income Statement

Concept	2020 Q1	2019 Q2	2019 Q1
Revenue	$9.012M	$7.720M	$6.430M
YoY Change	40.16%	56.91%	26.52%
Cost Of Revenue	$4.325M	$4.300M	$3.429M
YoY Change	26.13%	52.48%	38.66%
Gross Profit	$4.687M	$3.420M	$3.001M
YoY Change	56.18%	62.09%	15.02%
Gross Profit Margin	52.01%	44.3%	46.67%
Selling, General & Admin	$2.863M	$2.290M	$2.102M
YoY Change	36.2%	42.24%	28.88%
% of Gross Profit	61.08%	66.96%	70.04%
Research & Development	$1.391M	$1.250M	$1.269M
YoY Change	9.61%	14.68%	21.44%
% of Gross Profit	29.68%	36.55%	42.29%
Depreciation & Amortization	$184.0K	$180.0K	$127.0K
YoY Change	44.88%	63.64%	29.59%
% of Gross Profit	3.93%	5.26%	4.23%
Operating Expenses	$8.579M	$3.540M	$6.800M
YoY Change	26.16%	31.11%	32.06%
Operating Profit	$433.0K	-$120.0K	-$370.0K
YoY Change	-217.03%	-79.66%	452.24%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$14.00K	-$30.00K	$1.000K
YoY Change	-1500.0%	50.0%	-114.29%
Pretax Income	$419.0K	-$150.0K	-$369.0K
YoY Change	-213.55%	-75.81%	398.65%
Income Tax	$12.00K	$100.0K	$0.00
% Of Pretax Income	2.86%
Net Earnings	$75.00K	-$250.0K	-$369.0K
YoY Change	-120.33%	-60.32%	385.53%
Net Earnings / Revenue	0.83%	-3.24%	-5.74%
Basic Earnings Per Share	$0.03		-$0.03
Diluted Earnings Per Share	$0.03	-$21.57K	-$0.03
COMMON SHARES
Basic Shares Outstanding	11.75M shares		11.51M shares
Diluted Shares Outstanding	13.67M shares		11.51M shares

Balance Sheet

Concept	2020 Q1	2019 Q2	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.280M	$3.240M	$3.310M
YoY Change	-0.91%	276.74%	212.26%
Cash & Equivalents	$3.282M	$3.237M	$3.310M
Short-Term Investments
Other Short-Term Assets	$360.0K	$310.0K	$300.0K
YoY Change	20.0%	6.9%	57.89%
Inventory
Prepaid Expenses
Receivables	$4.493M	$4.377M	$3.919M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$8.130M	$7.922M	$7.527M
YoY Change	8.01%	56.56%	79.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.246M	$2.546M	$2.578M
YoY Change	25.91%	22.23%	30.2%
Goodwill	$669.0K	$669.0K	$669.0K
YoY Change	0.0%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$128.0K	$128.0K	$137.0K
YoY Change	-6.57%	10.34%	28.04%
Total Long-Term Assets	$6.945M	$3.343M	$3.384M
YoY Change	105.23%	10.77%	16.45%
TOTAL ASSETS
Total Short-Term Assets	$8.130M	$7.922M	$7.527M
Total Long-Term Assets	$6.945M	$3.343M	$3.384M
Total Assets	$15.08M	$11.27M	$10.91M
YoY Change	38.16%	39.45%	53.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.215M	$2.807M	$2.116M
YoY Change	4.68%	30.32%	7.9%
Accrued Expenses	$978.0K	$1.180M	$641.0K
YoY Change	52.57%	107.38%	75.62%
Deferred Revenue	$4.586M	$4.022M	$4.723M
YoY Change	-2.9%	-14.5%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$180.0K	$20.00K	$220.0K
YoY Change	-18.18%	-33.33%	633.33%
Total Short-Term Liabilities	$8.446M	$8.025M	$7.704M
YoY Change	9.63%	7.67%	24.72%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Long-Term Liabilities	$151.0K	$151.0K	$151.0K
YoY Change	0.0%	0.0%	-66.14%
Total Long-Term Liabilities	$151.0K	$151.0K	$151.0K
YoY Change	0.0%	0.0%	-66.14%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.446M	$8.025M	$7.704M
Total Long-Term Liabilities	$151.0K	$151.0K	$151.0K
Total Liabilities	$11.90M	$9.027M	$8.588M
YoY Change	38.54%	11.79%	29.67%
SHAREHOLDERS EQUITY
Retained Earnings	-$70.60M	-$70.70M	-$70.40M
YoY Change	0.28%	-0.18%	0.29%
Common Stock	$73.80M	$72.94M	$72.77M
YoY Change	1.42%	1.19%	1.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Treasury Stock Shares		0.000 shares	0.000 shares
Shareholders Equity	$5.513M	$2.137M	$2.323M
YoY Change
Total Liabilities & Shareholders Equity	$15.08M	$11.27M	$10.91M
YoY Change	38.16%	39.45%	53.78%

Cashflow Statement

Concept	2020 Q1	2019 Q2	2019 Q1
OPERATING ACTIVITIES
Net Income	$75.00K	-$250.0K	-$369.0K
YoY Change	-120.33%	-60.32%	385.53%
Depreciation, Depletion And Amortization	$184.0K	$180.0K	$127.0K
YoY Change	44.88%	63.64%	29.59%
Cash From Operating Activities	$280.0K	$250.0K	$1.210M
YoY Change	-76.86%	2400.0%	175.0%
INVESTING ACTIVITIES
Capital Expenditures	-$170.0K	-$140.0K	-$200.0K
YoY Change	-15.0%	-33.33%	150.0%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change
Cash From Investing Activities	-$170.0K	-$140.0K	-$200.0K
YoY Change	-15.0%	-33.33%	150.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	390.0K	-190.0K	350.0K
YoY Change	11.43%	1800.0%	1066.67%
NET CHANGE
Cash From Operating Activities	280.0K	250.0K	1.210M
Cash From Investing Activities	-170.0K	-140.0K	-200.0K
Cash From Financing Activities	390.0K	-190.0K	350.0K
Net Change In Cash	500.0K	-80.00K	1.360M
YoY Change	-63.24%	-61.9%	248.72%
FREE CASH FLOW
Cash From Operating Activities	$280.0K	$250.0K	$1.210M
Capital Expenditures	-$170.0K	-$140.0K	-$200.0K
Free Cash Flow	$450.0K	$390.0K	$1.410M
YoY Change	-68.09%	77.27%	171.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q2	csbr	Assetsin Progress Gross AssetsinProgressGross	16000	USD
CY2020Q1	csbr	Assetsin Progress Gross AssetsinProgressGross	0	USD
CY2018Q3	csbr	Finance Lease Cost FinanceLeaseCost	266000	USD
CY2019Q4	csbr	Finance Lease Cost FinanceLeaseCost	231000	USD
	csbr	Finance Lease Cost FinanceLeaseCost	149000	USD
CY2018Q3	csbr	Finance Lease Monthly Payment FinanceLeaseMonthlyPayment	11000	USD
CY2019Q4	csbr	Finance Lease Monthly Payment FinanceLeaseMonthlyPayment	19000	USD
CY2019Q2	csbr	Future Minimum Lease Payments Due FutureMinimumLeasePaymentsDue	11477000	USD
CY2019Q2	csbr	Future Minimum Lease Payments Due In Five Years FutureMinimumLeasePaymentsDueInFiveYears	1419000	USD
CY2019Q2	csbr	Future Minimum Lease Payments Due In Four Years FutureMinimumLeasePaymentsDueInFourYears	1404000	USD
CY2019Q2	csbr	Future Minimum Lease Payments Due In Three Years FutureMinimumLeasePaymentsDueInThreeYears	1445000	USD
CY2019Q2	csbr	Future Minimum Lease Payments Due In Two Years FutureMinimumLeasePaymentsDueInTwoYears	1471000	USD
CY2019Q2	csbr	Future Minimum Lease Payments Due Next Twelve Months FutureMinimumLeasePaymentsDueNextTwelveMonths	1338000	USD
CY2019Q2	csbr	Future Minimum Lease Payments Due Thereafter FutureMinimumLeasePaymentsDueThereafter	4400000	USD
	csbr	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	261000	USD
	csbr	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	299000	USD
	csbr	Noncash Or Part Noncash Acquisition Fixed Assets Acquired Unpaid Portion NoncashOrPartNoncashAcquisitionFixedAssetsAcquiredUnpaidPortion	0	USD
	csbr	Noncash Or Part Noncash Acquisition Fixed Assets Acquired Unpaid Portion NoncashOrPartNoncashAcquisitionFixedAssetsAcquiredUnpaidPortion	321000	USD
	csbr	Numberof Operating Subsidiaries NumberofOperatingSubsidiaries	2	subsidiary
CY2019Q4	csbr	Present Value Minimum Future Obligations Interest Rate PresentValueMinimumFutureObligationsInterestRate	0.0475
	csbr	Reversalof Provisionfor Doubtful Accounts ReversalofProvisionforDoubtfulAccounts	53000	USD
	csbr	Reversalof Provisionfor Doubtful Accounts ReversalofProvisionforDoubtfulAccounts	218000	USD
	csbr	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Grant In Period Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantInPeriodWeightedAverageRemainingContractualTerm	P5Y2M15D
	csbr	Share Based Compensation Arrangement By Share Based Payment Award Options Canceled In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod	4583	shares
CY2019Q2	csbr	Share Based Compensation Arrangement By Share Based Payment Award Warrants Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstanding	1671440	shares
CY2020Q1	csbr	Share Based Compensation Arrangement By Share Based Payment Award Warrants Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstanding	1669773	shares
	csbr	Share Based Compensation Arrangements By Share Based Payment Award Options Canceled In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice	11.90
CY2020Q1	csbr	Working Capital Deficit WorkingCapitalDeficit	300000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--04-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Document Period End Date DocumentPeriodEndDate	2020-01-31
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000771856
CY2020Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	11887649	shares
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	CHAMPIONS ONCOLOGY, INC.
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Small Business EntitySmallBusiness	true
CY2019Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2807000	USD
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2215000	USD
CY2019Q2	us-gaap	Accounts Receivable Gross AccountsReceivableGross	1982000	USD
CY2020Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	3073000	USD
CY2019Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	4399000	USD
CY2020Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	4723000	USD
CY2019Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4377000	USD
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4493000	USD
CY2019Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1180000	USD
CY2020Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	978000	USD
CY2019Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2074000	USD
CY2020Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2526000	USD
CY2019Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	72924000	USD
CY2020Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	73790000	USD
CY2018Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	75000	USD
CY2018Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	88000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	335000	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	131000	USD
CY2019Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	77000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	229000	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	335000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	498000	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	229000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	437000	USD
CY2019Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	22000	USD
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	230000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4161608	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4036371	shares
CY2019Q2	us-gaap	Assets Assets	11265000	USD
CY2020Q1	us-gaap	Assets Assets	15075000	USD
CY2019Q2	us-gaap	Assets Current AssetsCurrent	7922000	USD
CY2020Q1	us-gaap	Assets Current AssetsCurrent	8130000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	160000	USD
CY2019Q2	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	16000	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	235000	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	212000	USD
CY2019Q2	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	1104000	USD
CY2020Q1	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	1194000	USD
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3237000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3282000	USD
CY2018Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1006000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3310000	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3237000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3282000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2304000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	45000	USD
CY2019Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2019Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11823274	shares
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11619538	shares
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11823274	shares
CY2019Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11619538	shares
CY2019Q2	us-gaap	Common Stock Value CommonStockValue	12000	USD
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	12000	USD
CY2019Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4022000	USD
CY2020Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4586000	USD
CY2019Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4022000	USD
CY2020Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4586000	USD
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3429000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9963000	USD
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4325000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	11958000	USD
CY2019Q2	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	851000	USD
CY2019Q1	us-gaap	Depreciation Depreciation	127000	USD
	us-gaap	Depreciation Depreciation	353000	USD
CY2020Q1	us-gaap	Depreciation Depreciation	184000	USD
	us-gaap	Depreciation Depreciation	491000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	433000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	579000	USD
CY2020Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	8300	USD
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2020Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	35400	USD
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	35400	USD
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2019Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	0	USD
CY2020Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	177000	USD
CY2019Q4	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	193000	USD
CY2020Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2000	USD
CY2019Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	366000	USD
CY2020Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	343000	USD
CY2019Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	142000	USD
CY2020Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	181000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	52000	USD
CY2019Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1223000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3311000	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1556000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4118000	USD
CY2019Q2	us-gaap	Goodwill Goodwill	669000	USD
CY2020Q1	us-gaap	Goodwill Goodwill	669000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-369000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	381000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	419000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	110000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	38000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-46000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-913000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	55000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	334000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	72000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-202000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	19000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	564000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	21000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	0	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	11000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	47000	USD
	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	-279000	USD
	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	0	USD
CY2019Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	2651749	shares
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1921053	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1787746	shares
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	8000	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
CY2020Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0725
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	10486000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	4400000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1419000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1404000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	53000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	693000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	693000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1445000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1471000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	347000	USD
CY2019Q2	us-gaap	Liabilities Liabilities	9027000	USD
CY2020Q1	us-gaap	Liabilities Liabilities	11898000	USD
CY2019Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11265000	USD
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15075000	USD
CY2019Q2	us-gaap	Liabilities Current LiabilitiesCurrent	8025000	USD
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	8446000	USD
CY2019Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	3358000	USD
CY2020Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	4397000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1387000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	378000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-693000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-693000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1610000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	360000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	483000	USD
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	267000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-369000	USD
	us-gaap	Net Income Loss NetIncomeLoss	381000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-641000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	307000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	407000	USD
	us-gaap	Net Income Loss NetIncomeLoss	72000	USD
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-369000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	381000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	407000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	72000	USD
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	6800000	USD
	us-gaap	Operating Expenses OperatingExpenses	18962000	USD
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	8579000	USD
	us-gaap	Operating Expenses OperatingExpenses	23266000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-370000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	386000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	433000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	109000	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	717000	USD
CY2020Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	490000	USD
CY2020Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3301000	USD
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2902000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	583000	USD
CY2019Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	128000	USD
CY2020Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	128000	USD
CY2019Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	151000	USD
CY2020Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	151000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	51000	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-14000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1000	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5000	USD
CY2019Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	308000	USD
CY2020Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	355000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1440000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	429000	USD
CY2019Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4620000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5772000	USD
CY2019Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2546000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3246000	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1269000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3550000	USD
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1391000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4035000	USD
CY2019Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-70698000	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-70625000	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-70600000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6430000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19348000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9012000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	23375000	USD
	us-gaap	Revenue Performance Obligation Description Of Timing RevenuePerformanceObligationDescriptionOfTiming	The majority of the Company's revenue arrangements are service contracts that are complete within a year or less. There are a few contracts that range in duration between 1 and 3 years.
CY2019Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	879000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2138000	USD
CY2020Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1307000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3155000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	498000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	437000	USD
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1914035	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.72
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	76669	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	41875	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	219833	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.76
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.03
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.56
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.09
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	14557000	USD
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	10594000	USD
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2423626	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2316596	shares
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.19
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.22
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	10594000	USD
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2316596	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	3.22
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost	7500	USD
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.10
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	8.04
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	7.99
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.29
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	9695000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y5M40D
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y3M19D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y2M15D
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	203736	shares
CY2018Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	42000	USD
CY2018Q4	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1034000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	365000	USD
CY2019Q4	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	2000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	427000	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	3000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	603000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	1992000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	2323000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	2238000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	1728000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	2114000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	3177000	USD
CY2019Q2	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	2417000	USD
CY2020Q1	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	1650000	USD
CY2019Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	151000	USD
CY2020Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	151000	USD
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11508180	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13909063	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13673672	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13440861	shares
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11508180	shares
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11508180	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11257314	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11257314	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11752619	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11752619	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11653115	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11653115	shares

Files In Submission

Name	View Source	Status
0001628280-20-003637-index-headers.html	Edgar Link	pending
0001628280-20-003637-index.html	Edgar Link	pending
0001628280-20-003637.txt	Edgar Link	pending
0001628280-20-003637-xbrl.zip	Edgar Link	pending
csbr-20200131.xml	Edgar Link	completed
csbr-20200131.xsd	Edgar Link	pending
csbr-20200131_cal.xml	Edgar Link	unprocessable
csbr-20200131_def.xml	Edgar Link	unprocessable
csbr-20200131_lab.xml	Edgar Link	unprocessable
csbr-20200131_pre.xml	Edgar Link	unprocessable
csbr10-q1312020.htm	Edgar Link	pending
csbrq3131202010-qex311.htm	Edgar Link	pending
csbrq3131202010-qex312.htm	Edgar Link	pending
csbrq3131202010-qex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CSBR
CHAMPIONS ONCOLOGY, INC. Stock $csbr

2020 Q1 Form 10-Q Financial Statement

#000162828020003637 Filed on March 16, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CSBR CHAMPIONS ONCOLOGY, INC. Stock $csbr

2020 Q1 Form 10-Q Financial Statement

#000162828020003637 Filed on March 16, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CSBR
CHAMPIONS ONCOLOGY, INC. Stock $csbr